RxDoctor Payments Data

Alex Pulido

Internal Medicine · Palatka, FLNPI 1629218474

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.0% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Novo Nordisk at 44.9% of the total. Reporting peaked in 2021 at $798 and has fallen 94.9% since, to $41 in 2022.

$2,179in general payments, 2019–2025

Across 156 payments — averaging $13.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$979
  • Lilly USA, LLC$533
  • GSK$132
  • AstraZeneca$116
  • Astellas Pharma US Inc$100
  • Philips North America LLC$54
  • plus $266 from 12 others

What the payments were for

  • Food & beverage$2,00692%
  • Education$1738%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,179 in reported general payments places this provider in the 80th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Other internal medicine in Palatka

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →